ROS1 Expression Correlates With Inguinal Lymph Node Affection in Vulvar Cancer Patients: A Retrospective Study
ABSTRACT Purpose Systemic treatment options for vulvar squamous cell carcinoma (VSCC) are limited. ROS1, a tyrosine kinase implicated, for example, in non‐small cell lung cancer (NSCLC), has recently shown responsiveness to tyrosine kinase inhibitors. This study investigated immunohistochemical ROS1...
Saved in:
| Main Authors: | Meletios P. Nigdelis, Annick Bitterlich, Mariam Parvanta, Bashar Haj Hamoud, Erich Franz Solomayer, Martin Ertz, Laura Schnöder, Annette Hasenburg, Bernd Holleczek, Mathias Wagner, Gilbert Georg Klamminger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.71160 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vulvar sarcomas: clinical and morphological observations and a review of literature
by: E. V. Korzhevskaya, et al.
Published: (2014-08-01) -
High Prevalence of Human Papillomavirus in Vulvar Cancer Among Vietnamese Women: Implications for Vaccination Strategies
by: D. N. L. Tran, et al.
Published: (2025-06-01) -
Topical issues of prevention, diagnosis and treatment of vulvar and vaginal cancer
by: A. G. Solopova, et al.
Published: (2019-02-01) -
Modern methods of treatment of precancerous vulvar diseases, with a focus on photodynamic therapy: literature review
by: N. A. Shanazarov, et al.
Published: (2025-06-01) -
Human papillomavirus in vulvar cancer: a systematic review
by: D. S. Dolgasheva, et al.
Published: (2025-07-01)